5-fluorouracil topical (SiSaf)

N/A

Report date: 2025/07/11 16:10:34

Base Information

Drug Name5-fluorouracil topical (SiSaf)
Drug Alias NameSIS-022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsCicatrix, HypertrophicKeratosis, ActinicBowen's Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiSaf Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSiSaf Ltd
Inactive CompaniesN/A
Active IndicationsCicatrix, HypertrophicKeratosis, ActinicBowen's Disease +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A